Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Marc Rubin Insider Profile
4 Followers
Marc Rubin, EC, Director at Titan Pharmaceuticals, holds 13.58K shares in Galectin Therapeutics (Ticker: GALT), holds 28.82K shares in Curis (Ticker: CRIS), holds 556.32K shares in Titan Pharmaceuticals (Ticker: TTNP).
Profitable Transactions
4 out of 6 Profitable Transactions
Average Return
+19.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Marc Rubin holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Dec 08, 2017 - Dec 08, 2018
Return:+104.50%
The most profitable trade made by Marc Rubin
Marc Rubin's Trading History
Titan Pharmaceuticals
Sep 25, 2018
EC, Director
Informative Buy
100.00K
$3.82M
Galectin Therapeutics
Feb 25, 2019
Director
Uninformative Sell
307.99K
$47.13K
Curis
Jan 25, 2019
Director
Uninformative Sell
19.43K
$466.00K
List of latest transactions for each holding click on a transaction to see Marc Rubin's performance on stock
You May Also Like
Marc Rubin insider profile FAQ
What is the percentage of profitable transactions made by Marc Rubin?
The percentage of profitable transactions made by Marc Rubin is 67%.
What is the average return per transaction made by Marc Rubin?
The average return per transaction made by Marc Rubin is 19.80%.
What stocks does Marc Rubin hold?
Marc Rubin holds: TTNP, GALT, CRIS stocks.
What was Marc Rubin’s latest transaction?
Marc Rubin latest transaction was an Uninformative Sell of $307.99K.
What was Marc Rubin's most profitable transaction?
Marc Rubin’s most profitable transaction was an Informative Buy of GALT stock on December 8, 2017. The return on the trade was 104.50%.
What is Marc Rubin's role in Titan Pharmaceuticals?
Marc Rubin's role in Titan Pharmaceuticals is EC, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.